articleMolecular TherapyJul 2, 2025GREEN OA

Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR T and NK cell generation

JIJames I. AndorkoRMRonnie M. RussellBCBruce C. SchneppDGDaniel GrubaughKFKarla F Mullen

Integrated BioTherapeutics (United States) · Fresenius Kabi (Czechia)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

43
total citations
FWCI
34.23
Percentile
100%
References
56
Citations per year

Authors

11

Topics & keywords

Topics
Keywords
  • In vivo
  • Viral vector
  • Gene delivery
  • Vector (molecular biology)
  • Lentivirus
  • Virology
  • Genetic enhancement
  • Biology
No related works found for this paper.